NCT05911256Enrolling by invitation
A Community Health Worker/Pharmacist Team to Improve Blood Sugars in Diabetes Care Using Continuous Glucose Monitoring
TEAM Support to Improve Glycemic Control Using CGM in Diverse Populations
Source: ClinicalTrials.gov · Last updated 4 Sept 2026
Brief summary (registry, in English)
Continuous glucose monitoring (CGM) can help improve blood sugar management in type 2 diabetes. A sequential, multiple assignment, randomized trial will evaluate clinical pharmacists, community health workers, and telehealth in supporting CGM use to improve blood sugar control.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 318 (estimated)
- First submitted
- 12 Jun 2023
- Start date
- 27 Sept 2024
- Primary completion date
- Mar 2028
- Lead sponsor
- University of Massachusetts, Worcester
- Diseases
- Type 2 diabetes
- NCT number
- NCT05911256
What you commit to
- Study type: Interventional
- Planned participants: 318
- From 27 Sept 2024 to the primary completion date, Mar 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Plans for weight reduction surgery or prescription weight loss medication (specific for weight loss, not GLP-1).
- Current use of steroids.
- Abuse of illicit drugs.
Other illness
- Specific comorbidities (e.g., recent MI, TIA, CVA, malignancy, hemoglobinopathy, severe hypoglycemia, etc.).
- Psychiatric disorder that may limit ability to perform study tasks
- Skin changes that preclude use of sensor or allergy to adhesive.
Other
- Current, recent, or planned use of CGM.
- Pregnancy (or planned pregnancy).
- Planning to leave geographic area within 12 months or distance from clinical site \> 20 miles.
- Participation in another study.
Who the study is looking for
- Age 25-75.
- History of T2DM \> 1 year.
- Speak English or Spanish.
- A1c ≥ 8% (within past 6 months) - with reduction if necessary based on recruitment.
- eGFR (estimated glomerular filtration rate) \> 30.
- Willingness to use continuous glucose monitoring (CGM) and work with a community health worker (including home visits) and clinical pharmacist.
Age in the registry: 25 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Massachusetts Coordinator of this site? Confirm its status | Worcester | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.